Javascript must be enabled to continue!
The Effect of Periodontitis Treatment on Anti-DSDNA Titer in Patients with Systemic Lupus Erythematosus
View through CrossRef
Aim: Systemic Lupus Erythematosus (SLE) and periodontitis are both inflammatory diseases. It has been revealed that may be an association exists between them. Inflammation in chronic periodontitis causes gingival erosion and alveolar bone destruction. According to available sources, chronic inflammation due to periodontal disease has a negative effect on Anti-dsDNA as one of the most important laboratory indicators of SLE. The aim of this research is to evaluate the effect of periodontal treatment on Anti-dsDNA titer in patients with SLE.
Materials and methods: The samples were selected from well controlled patients with SLE . In the initial visit, the laboratory factor “Anti-dsDNA” was recorded from the patients. Patients with periodontal disease were divided into case and control groups by block randomization method. For the case group, scaling was done with an ultrasonic device and oral health education was provided to all patients. The patients were asked to return 3 months after the periodontal treatment to evaluate the level of disease activity and the response to periodontal treatment. For data analysis, SPSS 18 program and Mann-Whitney non-parametric test was used.
Results: The average duration of the disease in this study was 6.89 ± 6.56 years. Comparison of the average Anti-dsDNA autoantibody titer before and after treatment in the intervention group considering that there was no normality between the data and there was a statistically significant difference between the average Anti-DsDNA titer before and after the intervention in the subject group.
Conclusion: Since the phase 1 of periodontal treatment as a modifiable risk factor has led to a significant change in Anti-dsDNA titer and this antibody is an indicator of disease flare, periodontal treatment is recommended separately from the reactivation of the disease and to promote the disease control.
Title: The Effect of Periodontitis Treatment on Anti-DSDNA Titer in Patients with Systemic Lupus Erythematosus
Description:
Aim: Systemic Lupus Erythematosus (SLE) and periodontitis are both inflammatory diseases.
It has been revealed that may be an association exists between them.
Inflammation in chronic periodontitis causes gingival erosion and alveolar bone destruction.
According to available sources, chronic inflammation due to periodontal disease has a negative effect on Anti-dsDNA as one of the most important laboratory indicators of SLE.
The aim of this research is to evaluate the effect of periodontal treatment on Anti-dsDNA titer in patients with SLE.
Materials and methods: The samples were selected from well controlled patients with SLE .
In the initial visit, the laboratory factor “Anti-dsDNA” was recorded from the patients.
Patients with periodontal disease were divided into case and control groups by block randomization method.
For the case group, scaling was done with an ultrasonic device and oral health education was provided to all patients.
The patients were asked to return 3 months after the periodontal treatment to evaluate the level of disease activity and the response to periodontal treatment.
For data analysis, SPSS 18 program and Mann-Whitney non-parametric test was used.
Results: The average duration of the disease in this study was 6.
89 ± 6.
56 years.
Comparison of the average Anti-dsDNA autoantibody titer before and after treatment in the intervention group considering that there was no normality between the data and there was a statistically significant difference between the average Anti-DsDNA titer before and after the intervention in the subject group.
Conclusion: Since the phase 1 of periodontal treatment as a modifiable risk factor has led to a significant change in Anti-dsDNA titer and this antibody is an indicator of disease flare, periodontal treatment is recommended separately from the reactivation of the disease and to promote the disease control.
.
Related Results
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Background
Cutaneous involvement is very common in systemic lupus erythematosus. We describe the prevalence and spectrum of lupus-specific (cutaneous lupus eryt...
Systemic Lupus Erythematosus with and without Anti‐dsDNA Antibodies: Analysis from a Large Monocentric Cohort
Systemic Lupus Erythematosus with and without Anti‐dsDNA Antibodies: Analysis from a Large Monocentric Cohort
Objectives. The anti‐dsDNA antibodies are a marker for Systemic Lupus Erythematosus (SLE) and 70–98% of patients test positive. We evaluated the demographic, clinical, laboratory, ...
Association of anti dsDNA antibodies titer with non-renal manifestations of Systemic Lupus Erythematosus and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)
Association of anti dsDNA antibodies titer with non-renal manifestations of Systemic Lupus Erythematosus and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)
Background: Early diagnosis and effective treatment in systemic lupus erythematosus (SLE) has very crucial role. Anti dsDNA is very important diagnostic tool and activity marker in...
Study on the Diagnostic Value of Two dsDNA Antibodies in Patients with Systemic Lupus Erythematosus
Study on the Diagnostic Value of Two dsDNA Antibodies in Patients with Systemic Lupus Erythematosus
Objective: This study investigates the relationship between serum dsDNA antibody levels and disease activity in systemic lupus erythematosus (SLE) patients. Design: Collect SLE and...
Precision medicine and patient perspectives in systemic lupus erythematosus
Precision medicine and patient perspectives in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is an autoimmune disease (AID) with diverse clinical presentations and complex immunopathogenesis. Its chronic and variable co...
Precision medicine and patient perspectives in systemic lupus erythematosus
Precision medicine and patient perspectives in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is an autoimmune disease (AID) with diverse clinical presentations and complex immunopathogenesis. Its chronic and variable co...
Crucial Role of Foxp3 Gene Expression and Mutation in Systemic Lupus Erythematosus, Inferred from Computational and Experimental Approaches
Crucial Role of Foxp3 Gene Expression and Mutation in Systemic Lupus Erythematosus, Inferred from Computational and Experimental Approaches
The impaired suppressive function of regulatory T cells is well-understood in systemic lupus erythematosus. This is likely due to changes in Foxp3 expression that are crucial for r...
Serological Profiles of Systemic Lupus Erythematosus in Humanized Mice and Pristane-Induced Lupus Models
Serological Profiles of Systemic Lupus Erythematosus in Humanized Mice and Pristane-Induced Lupus Models
Highlights:1. This study compared the serological markers of pristane-induced mice to humanized mouse models of lupus achieved by transplanting stem cells from lupus patients, whic...

